데이터가 없습니다.

1. An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers [ ADVANCED SCIENCE ] - 2021.12.01
2. Undervaluation of Radiotherapy for Gross Desmoid Tumors: The Need for Absolute Volume Assessment [ IN VIVO ] - 2021.05.01
3. Clinical implementation of a wide-field electron arc technique with a scatterer for widespread Kaposi’s sarcoma in the distal extremities [ SCIENTIFIC REPORTS ] - 2020.06.16
4. The value of prophylactic cranial irradiation in limited-stage small cell lung cancer: should it always be recommended? [ Radiation oncology journal ] - 2019.09.30
5. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma [ Radiation Oncology ] - 2019.07.04
6. Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer [ Clinical Lung Cancer ] - 2018.03.01
7. A 10-year clinical outcome of radiotherapy as an adjuvant or definitive treatment for primary tracheal adenoid cystic carcinoma [ Radiation Oncology ] - 2017.12.04
8. A strategy for actualization of active targeting nanomedicine practically functioning in a living body [ BIOMATERIALS ] - 2017.10.01
9. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma [ ANTICANCER RESEARCH ] - 2017.08.01
10. Ibulocydine sensitizes human hepatocellular carcinoma cells toTRAIL-induced apoptosis via calpain-mediated Bax cleavage [ INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY ] - 2017.02.01
11. Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model [ Oncotarget ] - 2016.10.14
12. Postoperative Radiotherapy After Limb-sparing Surgery for Soft-tissue Sarcomas of the Distal Extremities [ ANTICANCER RESEARCH ] - 2016.09.01
13. Application of peptide displaying phage as a novel diagnostic probe for human lung adenocarcinoma [ AMINO ACIDS ] - 2016.04.01
14. Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer [ 대한방사선종양학회지 ] - 2015.12.09
15. Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis [ Radiation Oncology ] - 2015.12.03
16. Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer [ Radiation Oncology ] - 2015.11.21
17. Verification of accuracy of cyberknife tumor-tracking radiation therapy using patient-specific lung phantoms [ INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ] - 2015.07.15
18. Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging [ JOURNAL OF CONTROLLED RELEASE ] - 2015.06.10
19. Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer [ Radiation oncology journal ] - 2015.06.01
20. A cisplatin?incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity. [ INTERNATIONAL JOURNAL OF ONCOLOGY ] - 2015.03.01
21. Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening [ AMINO ACIDS ] - 2015.02.10
22. Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer. [ 대한방사선종양학회지 ] - 2014.06.01
23. Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma [ 대한방사선종양학회지 ] - 2011.12.30
24. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus [ LUNG CANCER ] - 2009.08.26
25. 진행된 하인두암에서 유도항암화학요법 후 방사선치료의 결과 [ 대한두경부종양학회 ] - 2008.11.29

1. EGFR-TKI 획득내성 인체폐암조직의 PDX 마우스에서 방사선반응 평가와 저항성 기전 연구 - 2020.03.01 ~ 2020.05.31
2. EGFR-TKI 획득내성 인체폐암조직의 PDX 마우스에서 방사선반응 평가와 저항성 기전 연구 - 2019.03.01 ~ 2020.02.29
3. 전자선호형치료법을 활용한 팔다리 피부 병변의 방사선치료법 개발 - 2019.01.01 ~ 2019.12.31
4. EGFR-TKI 획득내성 인체폐암조직의 PDX 마우스에서 방사선반응 평가와 저항성 기전 연구 - 2018.03.01 ~ 2019.02.28
5. 폐암 방사선 치료 극대화를 위한 표적 siRNA 전달체 및 치료 기술 개발 - 2018.01.01 ~ 2018.12.31
6. EGFR-TKI 획득내성 인체폐암조직의 PDX 마우스에서 방사선반응 평가와 저항성 기전 연구 - 2017.06.01 ~ 2018.02.28
7. 암줄기세포의 방사선저항성 극복을 통한 방사선치료효과 증진(3) - 2015.06.01 ~ 2016.05.31
8. 암줄기세포의 방사선저항성 극복을 통한 방사선치료효과 증진(2) - 2014.06.01 ~ 2015.05.31
9. 암줄기세포의 방사선저항성과 방사선치료효과 증진 - 2014.01.01 ~ 2014.12.31
10. 암줄기세포의 방사선저항성 극복을 통한 방사선치료효과 증진(1) - 2013.06.01 ~ 2014.05.31
11. 암줄기세포의 방사선저항성과 방사선치료효과 증진 - 2013.01.01 ~ 2013.12.31
12. Polymeric Nanoparticle(PNP)-항암제 개발 가속화 - 2012.12.01 ~ 2013.11.30
13. 비소세포폐암의 방사선치료 후 방사선폐렴의 발생양상에 대한 연구 - 2009.05.01 ~ 2010.04.30

데이터가 없습니다.

      데이터가 없습니다.

 공지